3月2日 - ** 医疗保险公司Elevance HealthELV.N股价盘前下跌3%至310美元
** 该公司称， (link)，医疗保险与医疗补助服务中心（CMS）计划从3月31日起停止新的医疗保险优势处方药注册，原因是该公司在2023年4月之前提交风险调整数据的方式存在问题。
** ELV表示，目前的会员将不会看到承保范围的变化，它已于去年4月修订了其做法；并补充说，它正在与CMS合作，但时间和结果仍不确定
** 2025 年股价下跌 5%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.